Foley Welcomes Prominent Life Sciences Patent Attorney Lauren L. Stevens in Silicon Valley

18 November 2010 Media Contact: Jill Chanen News

Addition Brings Significant In-house Pharmaceutical Experience.

Foley announced today that Dr. Lauren L. Stevens has joined the firm as Of Counsel in the Silicon Valley office, working with the Intellectual Property Department in the Chemical, Biotechnology & Pharmaceutical Practice.

Stevens focuses her practice on strategic client counseling and patent counseling in the pharmaceutical industry. She has significant experience with the preparation of validity, infringement, and freedom to operate opinions regarding chemical and pharmaceutical patents. In addition, she brings vast experience and knowledge of biopharma patent litigation, serving as Vice Chair of the American Intellectual Property Law Association’s (AIPLA) Hatch-Waxman Subcommittee in 2009. Stevens has substantial in-house legal experience, having served as vice president of legal and financial affairs at Affymax Research Institute and in other legal and corporate posts.

“Lauren’s addition, combined with the recent arrivals of Jerry Swiss, Lorna Tanner and their team last month, and our already strong team of intellectual property attorneys in the Silicon Valley office, creates one of the strongest pharmaceutical patent practices in Northern California,” said Paul A. Stewart, managing partner of Foley’s Silicon Valley office. “Her experience with IP due diligence and IP licensing in both biotechnology start-up and large pharmaceutical environments will also be valuable to our corporate practices both regionally and nationally. Her addition continues the rapid growth in 2010 of Foley’s Palo Alto office.”

“Lauren is an extraordinary attorney who brings a high level of knowledge and experience in the area of chemistry to the firm,” said Stephen B. Maebius, chair of Foley’s Intellectual Property Department. “She also brings with her a deep pool of contacts in the life sciences space and will be integral in expanding on our biotech and biopharma patent capabilities throughout the firm.”

Stevens advises national and international clients on patent and related issues spanning a variety of technologies in the pharmaceuticals industry.

Prior to joining Foley, Stevens was a partner at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, where she was a member of the Patent Transactions and Strategic Counseling practice.

Stevens is a frequent speaker on pharmaceutical patent law topics, including foreign filing strategies and FDA Orange Book listings.

Comprised of more than 200 attorneys, Foley’s Intellectual Property practice is a recognized leader in IP legal services. For the eighth consecutive year, Foley was ranked by IP Today as one of the top 10 firms for the number of patents issued and by IP Law & Business magazine as one of the top patent litigation firms in the nation.

Foley & Lardner LLP continually evolves to meet the changing legal needs of our clients. In a recent survey of Fortune 1000 corporate counsel*, Foley ranked first for superior client service and value. In addition, Foley was a Top 10 firm on the U.S. News – Best Lawyers® 2010 “Best Law Firms” list, based on the total number of first-tier metropolitan rankings, and CIO magazine recognized Foley for technological innovation that enhances business value by naming the firm to its prestigious CIO-100 list. With nearly 1,000 attorneys in 21 offices and more than 60 practices, Foley is recognized for providing high-caliber business and legal insight. Our team-based approach, proprietary client service technology, and practice depth enhance client relationships while seeing clients through their most complex legal challenges.

*The BTI Consulting Group (Wellesley, Massachusetts)

Related Services

Insights

Bad Holiday Season News! Estimates of an increase of Cyberattacks 20%!
13 December 2019
Internet, IT & e-Discovery Blog
Driving the Future of Automotive Technology
12 December 2019
Manufacturing Industry Advisor
Massachusetts Governor Proposes Facility Fee Ban
12 December 2019
Health Care Law Today
American Rule Prevails; PTO May Not Collect In-House Attorneys' Fees as "Expenses"
12 December 2019
IP Litigation Current
ACCC 46th Annual Meeting & Cancer Center Business Summit
04-05 March 2020
Washington, D.C.
Foley/Deloitte Compliance and Privacy Officer Roundtable
27 February 2020
Boston, MA
Let’s Talk Compliance
24 January 2020
Orlando, FL
New England Alliance Annual Meeting
15-17 January 2020
Woodstock, VT